PE 22-28 TREK-1 blocker, is the antidepressant angle real or just rodent hype?

Posted by curious_scientist in Research & News - 8 points, 5 comments.

Been reading up on PE 22-28 after it kept popping up in neuroplasticity discussions. The profile page here (/peptides/pe-22-28) says it blocks the TREK-1 potassium channel and supposedly produces fast antidepressant-like effects in animal models, faster than SSRIs. That is a pretty bold claim for something still preclinical.

What catches my eye is the mechanism. TREK-1 blockade enhancing serotonergic signaling and synaptogenesis makes sense on paper. But "antidepressant-like effects in mice" has burned a lot of us before. How many compounds looked amazing in rodents and went nowhere in humans? Too many, imo.

The short half-life bothers me too. If it is really short-lived, how would that even work practically for mood? You'd need frequent dosing or some delivery trick. And the safety profile is basically unknown in people. That is a big gap.

I have not tried it. Tempting because the cognitive and mood angle is exactly what I follow, but the lack of any human data makes me wanna wait. Imo the biohackers already running it are braver than I am.

Anyone here actually experimented with PE 22-28? Did you notice anything on mood or cognition, or was it just expensive water? Genuinely curious whether the animal data translates at all.

Comments

• midwest_scientist: I gave PE 22-28 a go a few months back – just a tiny sublingual dose each morning and evening for about ten days. Honestly I felt a tiny bump in mood on day three, a bit less irritability, but it could easily have been placebo or just a good night’s sleep. I didn’t notice any clear cognitive boost, and the short half‑life meant I had to watch the clock to redose. After the trial I stopped because the safety data in humans is basically nil and I didn’t want to keep guessing. Honestly it felt lik
• kenji_runs: Cheers for being honest about the placebo possibility, most people would've claimed it cured their depression. The short half-life thing is what puts me off tbh, sounds like a nightmare to actually evaluate properly. Did you track anything objective like sleep or HRV or was it all just subjective mood vibes? Reckon without some kind of metric it's basically impossible to separate signal from noise on something this subtle.
• curious_scientist: I haven’t actually tried PE‑22‑28 yet, so I have no sleep or HRV numbers to share. My comment was just from reading the papers and wondering if the short half‑life would make any real‑world mood effect measurable without objective markers.
• sleep_coastal: Anecdotally I tried a similar sublingual schedule a while back and also noticed only a fleeting mood lift that vanished after a couple days. Hard to tell if it was anything real. Curious if anyone stuck with it longer and saw anything clearer.
• curious_scientist: That fleeting lift then fade is exactly what I'd worry about with the short half-life. You said sublingual, so were you doing multiple doses per day or just once? Because if it was once and it still faded that fast, that tells me the mood effect might not even be sustained enough to chase, regardless of delivery route.
• curious_scientist: I’m still on the fence about trying it myself. What dose did you use sublingual each time? Did you notice any taste or mouth irritation? And did you track sleep or mood scales, or just go by feel?

Community discussion - research and educational context only. Not medical advice.